-
Conference Report - Protein Microarrays in Cancer and Autoimmunity: Tiny Spots Light up
New technologies that allow high throughput protein processing and identification, with quick delivery of reliable results, are being actively sought.
Journal Article, April 2004
-
Conference Report - Protein Kinase Inhibitors in Cancer Treatment: Mixing and Matching?
Only patients whose tumors depend on upregulation of these specific signaling pathways are likely to respond to treatment.
Journal Article, April 2004
-
Conference Report - Highlights of the 6th Joint Conference of the American Association for Cancer Research and the Japanese Cancer Association
The latest insights in DNA repair and susceptibility to lung cancer, inactivation of tumor suppressor genes, and mechanisms of bone metastasis
Journal Article, March 2004
-
Conference Report - Extracellular Matrix and Cancer: Revisiting Metalloproteinases
Has the last word been said on metalloproteinase inhibitors or are new findings raising new hopes?
Journal Article, February 2004
-
Conference Report - Tumor-Host Interactions: A Complex Network of Signals
Tumor cells grow within a complex microenvironment that may promote, sustain, or suppress their growth and metastatic activity. Which factors play a critical role?
Journal Article, February 2004
-
Conference Report - Highlights of the 4th EMBO/EMBL Joint Conference on Genetics, Determinism and Human Freedom
The "risk" for first-degree relatives of medical doctors to go to medical school is 80 times higher than for relatives of other professionals.
Journal Article, February 2004
-
Conference Report - Dendritic Cells: Myths and Reality
Dating, mating, and parenting -- is that how dendritic cells and T lymphocytes yield antigen-specific immune responses?
Journal Article, February 2004
-
Recurrent Carcinosarcoma of the Renal Pelvis
A 66-year-old male comes to observation with a painless hematuria of 1-month duration.
Journal Article, February 2004
-
Conference Report - II. Investigating New Vaccines: SARS
Sophisticated coronavirus vectors are being refined for use as SARS vaccines.
Journal Article, December 2003
-
Conference Report - I. Investigating New Vaccines: Ebola and HIV
An overview of the latest advances in epidemiology and vaccine design for Ebola and HIV infections.
Journal Article, December 2003
-
Conference Report - Breast Cancer Markers: What Next?
Which HER-2/neu assay yields the best results in most clinical settings?
Journal Article, November 2003
-
Conference Report - Clinical Pathology: The Top 5 Studies in the Journal
Leukoreduced transfusions, TPO and myeloproliferation, hyponatremia in marathoners, quality of human tissues, and molecular diagnosis of Mycobacteria are among the topics highlighted.
Journal Article, November 2003
-
Conference Report - Magic Markers for the Diagnosis of Thyroid Carcinomas?
An update on the diagnostic/prognostic features of old and new variants of papillary thyroid carcinoma
Journal Article, October 2003
-
Conference Report - Apoptosis -- A Graceful Death
Manipulation of extra- and intracellular signals may help to push cancer cells over the apoptotic edge -- PTEN and Bax on stage.
Journal Article, October 2003
-
Conference Report - Transfusions and TRALI: What Are the Risks Today?
TRALI, a potentially fatal acute lung injury, is one of the most frequent and underdiagnosed transfusion-related complications.
Journal Article, October 2003
-
Conference Report - Translational Research: Any Danger Lurking in Its Wake?
The availability of clinical and research mentors will be critical in determining whether a new wave of outstanding investigators will reach the trenches of clinical research.
Journal Article, August 2003
-
Conference Report - Dangerous Liaisons: Infections and Cancer -- Time for a Break-up?
Will large-scale HPV vaccination be implemented for worldwide prevention of cervical cancer?
Journal Article, August 2003
-
Conference Report - Plenary Session: From Genes to Cells to Metastasis
"Cancer is the most common genetic disease: in the western world, 1 in 3 people develops cancer, and 1 in 5 dies from it."
Journal Article, August 2003
-
Gene Profiling of Lymphoma, Myeloma, and AML
New genomic technologies promise significant
improvements in the molecular diagnosis and
prognosis of hematologic malignancies.
Journal Article, July 2003
-
Dissecting Oncogenes and Tyrosine Kinases in AML Cells
No single molecular abnormality is sufficient to induce
a leukemic phenotype.
Journal Article, July 2003
